Pregnancy and gamma/delta T cells: Taking on the hard questions
© Mincheva-Nilsson; licensee BioMed Central Ltd. 2003
Received: 06 July 2003
Accepted: 02 December 2003
Published: 02 December 2003
Considering the allograft rejection as one of the basic features of the immune system, the mammalian pregnancy is still a puzzling situation where the semiallogeneic embryo, a mating product of non-histocompatible individuals is not rejected. How are the demands of pregnancy solved in the context of the maternal immunity? How is the competent maternal immune system modulated during pregnancy? These are hard questions to answer and an intriguing challenge for immunologists to explain. Historically, the mammalian fetus has been regarded as a successful allograft, a tumor or a parasite [1, 2]. Although the mechanisms that promote the survival of the conceptus are at large still unknown, it has become increasingly clear that the maternal immune tolerance towards the fetus is the result of the interactions of a jigsaw puzzle of actors – cells, serum proteins, hormones, cytokines, enzymes and neurotransmitters.
The fetus is never in direct contact with uterine/maternal tissues. Instead, the contact is mediated through the placenta, a transient organ expressing preferentially paternal genes. Placental trophoblast cells come in close contact with the maternal tissues forming the so-called feto-maternal interface. There is no doubt that the maternal immune system is able to recognize and react to fetally derived antigens. However, the fetus is recognized in such a way that the major histocompatibility complex (MHC) – specific, acquired arm of the maternal immunity is suppressed [3, 4]. Instead, the maternal innate, first-line defense immune mechanisms are used and promoted during gestation [5, 6]. The γδT cells are an important component of the innate immune system recognizing allo- and/or self-antigens upon cell infection, stress or transformation. Both an effector and a regulatory role for γδT cells in vivo are well documented. Their overall function is to maintain homeostasis in the tissues where they reside [7, 8]. The constitutive presence of γδT lymphocytes at the feto-maternal interface [9–11] implies a possible role in the adaptation of the maternal immune system to the requirements of pregnancy.
The leukocyte population at the feto-maternal interface – decidua associated lymphoid tissue (DALT)
The largest of the leukocyte populations in decidua are the bone marrow derived CD56+bright/CD16- NK-like large granular lymphocytes (LGLs). These cells populate the uterine mucosa prior to implantation suggesting that the fetus does not play a direct role in their homing to the endometrium. Instead, circumstantial evidence implicates ovarian steroids and uterine decidualization as the main factors for the homing process . Their phenotype is CD16- CD56+bright CD57- CD2+ CD3-CD7+ CD4- CD8-, c-kit+, CD94+, resembling that of the circulating CD56+bright/CD16- NK cells [in ]. The murine counterpart of the CD56+bright cells does not express the CD56 molecule and its phenotype is Thy 1.1+, asialo-GM1+, interleukin (IL)-15R+. The CD56+bright/CD16- decidual NK cells produce a variety of cytokines, including granulocyte-macrophage-colony stimulating factor (GM-CSF), transforming growth factor (TGF) β1, interferon (IFN) γ, tumor necrosis factor (TNF) α, IL-2 and leukemia inhibitory factor (LIF) .
Although extensively studied the role of the CD56+bright/CD16- cells in human pregnancy is not yet established. In mice, a role for the decidual NK-like cells in the modification of the uterine blood vessels in the process of placenta formation has recently been suggested . In humans, an intriguing observation is that the CD56bright+/CD16-cells, numerous at early pregnancy, drastically drop at the second and third trimester and are practically absent at term. Moreover, they express c-kit and the recombinase activating genes (RAG) 1 and RAG2, suggesting TCR rearrangement processes or/and a progenitor nature of these cells [13, 17, 18].
General characteristics of the γδT cells
Comparison between TCRγδ and TCRαβ lymphocytes
Comparison between the γδT and αβT lymphocyte lineage
different from αβT cells
similar to αβT cells
CD4+ or CD8+
CD8+ or CD8αα (some)
non-peptide antigens from bacteria and plants
Frequency in blood
mucosae, epithelia, lymphoid tissues
blood lymphoid tissues (?)
blood, lymphoid tissues, mucosae
cytokine release (Th1/Th2)
wound repair (mice)
Vδ usage – a landmark for circulating and resident γδT cells
One major difference between the circulating and resident γδT cells is that they are using different variable (V) δ chains – the resident γδT cells are Vδ1+ while the circulating counterpart is Vδ2+. Recent studies of the phenotype of these two subsets in humans reveal that the Vδ2+ cells are similar in surface markers to the αβT cells while Vδ1 T cells have a phenotype more like mucosal lymphocytes and IELs [reviewed in ]. Resident γδT cells in epithelia are quite different in T-cell receptor repertoire and distribution from circulating γδT cells or αβT cells. These cells take up residence in the epithelial surfaces of the lung, intestine, uterus, vagina, tongue and murine skin . Although γδT cells develop in a thymic dependent manner, resident γδT cells can be thymus-independent and are detectable in athymic mice. Fetal liver and bone marrow progenitors can reconstitute the resident intraepithelial lymphocytes (IELs) in thymectomized recipients suggesting an alternative developmental pathway for the resident γδT cells . Thus, these two γδT cell subsets may develop from distinct lineages.
Antigen recognition by γδT cells
What do γδT cells see? Unlike the αβT cells, the TCRγδ cells are not MHC restricted. They seem to recognize antigens in a fundamentally different way than that of αβT cells, more similar to antibodies [7, 21]. Furthermore, there are differences in the recognition pattern of the circulating and resident γδT cells. Human resident Vδ1+ T cells seem to be inherently self-reactive. Some of these cells recognize CD1c, a member of non-polymorphic cell-surface glycoproteins structurally and evolutionarily related to MHC class I molecules. It is not clear if the CD1c-reactive Vδ1+ cells respond to CD1c molecules alone or with a self-lipid molecule . Vδ1+ cells have also been shown to recognize the newly defined MHC class I chain-related sequences A and B (MICA and MICB). These antigens are restricted to certain cell types of epithelial origin and are modulated by stress, inflammation, infection and cancer [7, 20, 24, 25].
In contrast to resident γδT cells, the human circulating γδT cells have been shown to recognize non-peptide antigens derived from microbes and plants. The well-defined non-peptide antigens recognized by circulating γδT cells are prenyl pyrophosphates, bisolphonates, and alkylamines . Thus, the recognition manner of γδT cells is dependent of the Vδ usage.
Functional characteristics of the γδT cells
What do the γδT cells do? The function of the γδT cells should again be discussed in the context of their location in the blood or in the tissues. Various mucosae are the natural habitat of resident, Vδ1+γδT cells. It is however not known if these cells take up residence as naive or as antigen-experienced memory-type of cells. Several reports [20, 26] have shown that resident γδT cells express cytotoxic molecules-perforin, granzymes and Fas ligand. Chemokines such as lymphotactin, MIP-1α and MIP-1β, the chemokine receptors CCR5 and CXCR3 and adhesion molecules are also expressed by γδT cells . Taken together, these data indicates the "activated yet resting" state of the γδT cells. The ability of the resident γδT cells to rest but at the same time display molecules engaged in effector functions is consistent with the presumption that these cells function as first-line defense rather than as a component of the adaptive immunity.
The circulating γδT cells, on the other hand, can react rapidly with non-peptide antigens upon encountering infections and thereby activate the innate immune cells and subsequently facilitate adaptive immune responses of αβT cells. Several reports have shown that circulating Vδ2+ γδT cells play a role in the elimination of infections with certain microbial pathogens such as intracellular bacteria like Mycobacterium tuberculosis, Francisella tularensis, Legionella micdadei, parasites like Plasmodium falciparum and Schistosoma Mansonii and the HIV virus [7, 27, 28]. Most studies have shown that the γδT cells play a role in bridging innate and adaptive immune responses. However, a fundamental question is whether circulating γδT cells have immunologic memory and can contribute to adaptive immune responses. In a non-human primate model of macaques infected with Mycobacterium bovis (BCG) strain was shown that circulating Vδ2+ cells which have undergone polyclonal expansion during a primary BCG vaccination can mount a memory/recall response following a secondary BCG infection [reviewed in ]. These studies provide evidence that Vδ2+cells like αβT cells are able to contribute to adaptive immune responses.
Accumulating evidence has been indicative of yet another, not less important and sophisticated role for primarily the resident γδT cells, than infection protection: tumor-surveillance- and immunoregulatory functions [7, 20, 25, 29]. Resident γδT cells may have a unique role in immune surveillance against malignancy. This immune function may have advantage over the αβT cells since resident γδT cells can directly recognize molecules expressed on cancer cells without antigen processing and presentation. The γδT cells have the ability to migrate as infiltrating lymphocytes in solid tumors [24, 30] and have been shown to react on inducible MICA/B molecules, thus recognizing and eliminating damaged/malignant/stressed (epithelial) cells and participating in the maintenance of homeostasis. Moreover, they can interact and modulate the activity of other immune cells directly or by cytokine production and thus function as regulatory cells. Although the exact mechanisms of these functions remain unclear, their ability to influence other immune cells provides them with the opportunity to modulate the course and outcome of a variety of immune and non-immune responses and to act in different ways depending on the particular microenvironment in which they are present.
γδT cells in pregnancy
The immunological challenge of viviparity is to exert immunosuppression of specific responses towards the fetus without compromising the ability to fight infection. From this point of view, the γδT cells, which combine unique functions of infection protection and immunoregulation (Table 1), are of particular interest during pregnancy. Classical polymorphic MHC molecules are absent in the trophoblast cells and class II molecules cannot be induced even after stimulation with IFNγ , thus a direct allostimulation of the maternal αβT cells is avoided. In line with this finding it has been proposed that lack of polymorphic MHC molecule expression on the trophoblast is a way to "hide" pregnancy from the immune system. There is, however, abundant hard evidence refuting this hypothesis. The successful pregnancy is indeed recognized by the immune system in a way promoting immunotolerance. TCRαβ-mediated recognition of fetal antigens, restricted to classical MHC molecules might provoke cytotoxic reaction toward the fetus and is unlikely to be promoted. The γδT cells, however, recognize a distinct group of ligands and antigens in a MHC-unrestricted manner and might play a key role in the immunological recognition of pregnancy.
Circulating γδT cells in human pregnancy
Human γδT cells in peripheral blood of women with normal pregnancy and recurrent abortions have been studied by Szekerez-Bartho et al. In healthy pregnant women, there was an accumulation of Vδ1+ circulating cells, in contrast to women with recurrent abortions where the Vδ2+ circulating cells dominated. The ratio of activated γδTCR+ cells was significantly increased in normal pregnancies compared to that of recurrent abortions [32, 33]. A bias towards circulating Vδ1+γδT cells seemed to be required for a successful normal pregnancy [32, 33]. However, the precise role of circulating γδT cells in pregnancy is not yet completely established. Although convenient to study the γδT subsets during pregnancy in the peripheral blood, it cannot be excluded that the circulating Vδ1+ cells might simply be a spill over from the feto-maternal interface, where they are resident constitutive inhabitants.
γδT cells at the feto-maternal interface
Phenotype and morphology
The vast majority of the human decidual γδT cells are Vδ1+ [13, 36]. Itohara et al.  and Heyborne et al.  have shown that the Vδ1 chain is also preferentially used by γδT cells in the uterus of normal and pregnant mice. Thus, the γδT cells in pregnant uterine mucosa, like other mucosa-associated γδT cells, are resident Vδ1+ cells.
Similar to resident γδT cells at other mucosal sites , the decidual γδT cells are activated but resting. We have shown that they posses a cytotoxic potency and express five major cytolytic molecules: perforin (Pf), granzyme A, granzyme B, granulysin and Fas ligand (FasL), and store them in microvesicles in intracytoplasmic cytolytic granules . Like other cytotoxic lymphocytes  the decidual γδT cells do not express FasL on their surface but store preformed FasL in the granules, and can rapidly mobilize it to the cell surface upon stimulation. Thus, the two major cytotoxic mechanisms – Pf- and FasL-mediated – are performed by one common secretory pathway based on cytolytic granule exocytosis . Cytotoxic mechanisms play a crucial role in the clearance of viral and bacterial infections, tumor surveillance, transplant rejection, homeostatic regulation of immune responses and peripheral tolerance . Logically these mechanisms should have an important function at the feto-maternal interface by protecting the maternal-fetal unit against pathogens, controlling invasion of placental trophoblast, and creating a local transient immunotolerance toward the semiallogeneic conceptus through deletion of fetus-reactive lymphocyte clones. Indeed, recent studies of Pf- and FasL-deficient mice have shown that although functional deletion of Pf or FasL alone does not appear to affect fertility, the combined absence of these two effector molecules induces infertility .
Decidual γδT cells proliferate and differentiate in situ – decidua as an extrathymic maturation site
Interestingly, we were able to stain γδT cells in mitosis  proving that the γδT cells divide in human decidua. As a rule, the plasma membrane of the mitotic cells was strongly stained with the reaction product indicating a high level of γδT cell receptor expression . Our finding of γδT cells dividing in situ is in line with previous suggestion that γδT cells might expand in epithelial sites exposed to external environmental antigens, and, in some cases, recognize self-antigens, specific to a particular local environment [7, 20, 27]. By analogy, decidual Vδ1+ T cells may recognize trophoblast-related antigens and be involved in controlling trophoblast invasion during placenta formation .
In previous reports, Hayakawa et al.  in the human system and Kimura et al.  in the murine system have shown expression of mRNA for RAG-1 and RAG-2 proteins, which are required for TCR rearrangement, in human CD56bright/CD16- cells and in murine decidual mononuclear cells respectively. We have confirmed and extended these results showing that transcripts of RAG can be easily detected in purified CD56+, CD2+, c-kit+ or IL-7R+ decidual cells implying an ongoing process of TCR gene rearrangement . There is no doubt that ongoing rearrangement of TCRγδ takes place in decidua, probably for two purposes: 1) local extrathymic differentiation of γδT cells by TCR receptor rearrangements and 2) secondary TCRγδ rearrangement, permitting editing of antigen receptors on mature cells, thus adjusting the decidual γδT-cell repertoire to the ongoing pregnancy. Re-induced RAG expression, involved in receptor editing is a phenomenon observed in immature T cells in thymus and seems to be required for the generation of normal T-cell repertoire . Although not proven yet it is reasonable to assume that both local TCRγδ receptor rearrangement and editing are equally used in decidua.
Is there a need for T-cell differentiation in decidua? What purpose and biological significance there might be for extrathymic T-cell differentiation during pregnancy?
We can argue for at least two different reasons for extrathymic maturation in pregnancy. The first reason is priming the maternal immune system to the fetus. The meeting between the mother and the fetus is dual: 1) between the maternal blood and syncytiotrophoblast cells of the chorion villi of the placenta and 2) between the extravillous trophoblast and the maternal epithelial, stromal, endothelial and immune cells in decidua when placenta is formed. It is reasonable to assume that the first encounter and antigen presentation of fetal antigens to the immune system takes place in decidua. Decidua/endometrium might enrich CD56+ progenitor cells of bone marrow origin which will further differentiate/rearrange locally (or naive thymus-derived T cells will edit their TCR) upon the encounter of fetal antigens. The extrathymic maturation in decidua might be one of the mechanisms adjusting the immune system and the T-cell repertoire towards acceptance of the ongoing pregnancy. Heyborne et al have shown that murine decidual γδT cells recognize trophoblast-derived antigens. Immune cells, locally primed in decidua might then repopulate the peripheral blood of the pregnant woman as suggested by published reports [reviewed in ].
The cytokine profile of the decidual γδT cells suggests regulatory functions
Cytokines at the fetomaternal interface play a pivotal role for the establishment and maintenance of normal pregnancy. Several well-performed studies in humans and mice have shown beyond doubt that there is a T-helper (Th) 2 bias in the cytokine response [reviewed in ]. But the role of cytokines in pregnancy cannot solely be explained by the Th2/Th1 paradigm. Although very attractive, there is a serious risk of oversimplifying this concept. First, a critical feature of the Th1/Th2 model is that the two cell types counter regulate one another via cytokine production. But the polarization of the Th1 versus Th 2 effector cells is rarely complete and simultaneous Th1 and Th2 responses are possible. Second, this concept is derived from results of in vitro experiments and experimental models with immunologically inactive, inbred laboratory mice. In reality, when faced with established responses, the Th1 effectors have little ability to down-regulate Th2 responses . Similarly, Th2 effector cells, carefully separated from the Th2-like regulatory cells, have been shown to aggravate, rather that inhibit Th1-mediated inflammatory responses . There is a compiling body of evidence that the T-cell function at the feto-maternal interface in successful pregnancy is modulated by a cytokine environment of IL-10 and TGF-β, cytokines that are not always viewed as Th2-type only . Abandoning the Th1/Th2 bias one can ask the question if other, non-Th1/Th2 cells and responses operate at the fetomaternal interface. Careful studies of decidual γδT cells in the murine system have shown that, TCRγδ+/asialoGM1+ cells and TCRγδ single positive cells  play a decisive role in pregnancy outcome depending on their cytokine response. At early preimplantation stage, murine γδT cells produce TNF-α, IFN-γ and probably IL-2 and promote abortions by activation of decidual NK cells and macrophages. At a later stage, during the time of implantation and placenta formation, the γδT cells in murine decidua produce TGF-β and IL-10 and exert anti-abortogenic effect [2, 49]. Using quantitative RT-PCR we have analyzed the cytokine profile of the two main subpopulations of γδT cells in human decidua: TCRγδ+/CD56+ and TCRγδ single positive cells [10, 13]. Our results  show that the TCRγδ+/CD56+ cells almost exclusively express mRNA for TGF-β1 and IL-10 cells suggesting orientation towards an immunosuppressive profile . Then as they further develop into primed TCRγδ single positive cells their IL-10 and TGF-β1 expression is strongly enhanced. Additionally, the TCRγδ single positive cells transcribe two more cytokines-IL-6, suggesting an orientation toward the pregnancy-promoting Th 2 response and IL-1β, a cytokine considered in general to have a function promoting maturation and clonal expansion of other lymphocyte subpopulations. In pregnancy in particular, IL-1β is considered to be an important factor for the implantation of the blastocyst in the uterine cavity acting through up-regulation of adhesion molecule expression . Our results  based on quantitative cytokine mRNA measurement in these two subpopulations of human decidual γδT cells indicates that these cells, by virtue of the strong dominance /exclusivity of IL-10/TGF-β mRNA expression can be ascribed to the newly "reborn" suppressor/regulatory T (Treg) cells. Furthermore, these cells express the regulatory T cell marker CTLA4 (Fig. 2). A brief summary of some of the characteristics of the Treg cells is given in Table 2.
Summary of some characteristics of the T regulatory cells
T regulatory (TREG) cells
Cells with regulatory function that produce IL-10 and TGF-β and play a critical role in the control the immune response and the generation and maintenance of tolerance.
• heterogeneous group of lymphocytes
• exist in very low numbers
• respond poorly to stimulation through TCR
• unique and diverse mechanisms of action
• none common specific phenotypic marker
3. Some subtypes by phenotype
• NT/NKT cells – e.g. Vα24-JαQ
4. Subtypes by cytokine profile
• Th3 cells: differentiate from naive CD4+ or CD8+ cells under the influence of TGF-β, produce TGF-β > IL-10, varying IL-4
• Tr1 cells: differentiate from naive CD4+ or CD8+ cells under the influence of IL-10, produce IL-10 > TGF-β, no IL-4
Recent data provide convincing evidence that a specialized population of Treg cells both do exist and play a critical role in the generation and maintenance of immunological tolerance in humans [reviewed in [48, 52]]. The Treg cells exert their suppressive activities on effector cells in remarkably low numbers . Several subsets of Treg cells have been described in a variety of experimental models. In the context of this discussion it is interesting to note that two human CD4+ Treg-cell subsets exert their regulatory effect via secretion of the immunosuppressive cytokines IL-10 and TGF-β. One subset includes the so-called T helper 3 (Th3) cells, distinguished from other T helper cells by their ability to produce high levels of TGF-β and varying levels of IL-10 and IL-4 . The other subset, termed T regulatory type 1 (Tr1) cells produces a significant level of IL-10, various levels of TGF-β and no IL-4 . The decidual γδT cells produce high amount of IL-10 followed by TGF-β and no IL-4  and thus belong to the Tr1 regulatory type of cells. The selective generation of different Treg cell subsets is determined by the cytokine microenvironment in which naive CD4+ T cells encounter antigen. This means that if priming of naive Th0 cells occurs in the presence of IL-10 or TGF-β they differentiate to Tr1 or Th3 cells respectively and become polarized to synthesis of IL-10 or TGF-β [reviewed in ]. The cell type(s) responsible for the creation of such unique cytokine microenvironments in vivo is a subject of discussions. γδT cells are excellent candidates for this role, because these cells can respond to broadly distributed self-antigens in stressed, damaged and transformed tissues and do not require classical antigen processing and MHC-restricted presentation . γδT cells have been implicated in the down regulation of immune responses in various inflammatory disorders and may acquire immunoregulatory properties at mucosal sites [reviewed in ]. A population of γδT cells producing the Tr1/Th3 – type cytokines IL-10 and TGF-β has been isolated from tumor-infiltrating lymphocytes. These γδT cells could play a role in the inhibition of immune responses to tumors . It was shown that aerosol or nasal inoculation of intact insulin resulted in expansion of γδT cells with an immunosuppressive anti-diabetogenic effect, mediated by IL-10 . Remarkably, only a small fraction of γδT cells was enough to prevent adaptive transfer of diabetes . Furthermore, γδT cells producing IL-10/TGF-β were reported to be a critical cell population for the induction of allograft- and testicular tolerance [57, 58].
Summing up the accounted data above an attractive hypothesis is that γδT cells act as cytokine-producing cells to create a decidual environment that actively tolerates the fetus . We suggest that pregnancy-related antigen(s) can activate decidual γδT cells causing them to release the immunosuppressive Tr1- and Th3-type cytokines IL-10 and TGF-β. Figure 3 illustrates two possible mechanisms by which these cells could induce local uterine tolerance towards the fetus. In the direct pathway the effector cells (cytotoxic T lymphocytes, NK cells, macrophages, dendritic and B cells) at the feto-maternal interface could be directly inhibited by IL-10 and TGF-β. In this pathway γδT cells function as Treg cells . In the indirect pathway γδT cells could mediate the tolerogenic effect through generation of primed Th0, mainly TCRαβ+ CD4+ (and probably CD8+) cells. Under the influence of IL-10 and TGF-β, these cells differentiate into IL-10 producing Tr1-type of cells and TGF-β producing Th3 type of cells which in their turn act suppressively on the effector cells. In this pathway the γδT cells are needed for generation of efferent suppressor cells, but are not suppressors themselves . These two pathways might function in parallel and exert immunosuppression in concert with each other. It cannot be excluded that other types of decidual cells such as dendritic cells could also participate in the immunoregulation . The model presented [, Fig. 3] is simplified but comprises one important mechanism for immunomodulation at the feto-maternal interface.
An evolutionarily important process such as the mammalian pregnancy is a paradox and a challenge for the immune system and must rely on several mechanisms acting in concert to modulate the maternal immunity. However, enough convincing evidence shows that the immune system per se is not necessary for reproduction. Mammals have to reproduce despite their immune system.
The dual mission of the immune system during pregnancy is to down-regulate the specific, adaptive immune responses without compromising the ability to fight infections and protect against tumor transformation. In this process the innate immunity is activated and used to compensate for the impairment of the adaptive immunity, and to fulfill the requirements of a competent maternal immune defense during pregnancy. From immunological point of view pregnancy is a innate immunity event and one of its components, the γδT cells with their unique properties among the lymphoid cells of the immune system, are particularly suited to effectuate in parallel specific effector mechanisms combined with immunoregulatory functions. The γδT cells in pregnancy are resident Vδ1+ lymphocytes that are permanent inhabitants of the decidual mucosa. They comprise about half of the decidual T-cell population, differentiate locally in uterus and thus prime on the ongoing pregnancy. Activated but silent, they have the potency to protect the feto-maternal unit against stressed, infected and/or transformed cells. Moreover, they express high amounts of mRNA for the immunoregulatory cytokines IL-10 and TGF-β in a pattern characteristic of Tr1 regulatory lymphocytes. This property delineates their other major role in reproduction – to function as direct or indirect immunosuppressors thus modulating the maternal immune system towards tolerance of the fetus.
Dr. Vladimir Baranov is gratefully acknowledged for critically reading the manuscript. This work is supported by grants from Cancerfonden (4565-B01-01XAB) and Lion's Cancer Research Foundation, Umeå University (AMP 03-350)
- Billingham RE: Transplantation immunity and the maternal-fetal relation. N Engl J Med. 1965, 270: 667-672.View Article
- Arck P, Dietl J, Clark D: From the decidual cell internet: trophoblast-recognizing T cells. Biol Reprod. 1999, 60: 227-233.View ArticlePubMed
- Ait-Azzouzene D, Gendron MC, Houdayer M, Langkopf A, Burki K, Nemazee D, Kanellopoulus-Langevin C: Maternal B lymphocytes specific for paternal histocompatibility antigens are partially deleted during pregnancy. J Immunol. 1998, 161: 2677-2683.PubMed
- Jiang SP, Vacchio MS: Multiple mechanisms of peripheral T cell tolerance to the fetal "allograft". J Immunol. 1998, 160: 3086-3090.PubMed
- Mincheva-Nilsson L: Immune cells in pregnant uterine mucosa – functional properties, cellular composition and tissue organization. Umeå University Medical Dissertations New series No 384 ISSN 0346-6612. 1993
- Sacks G, Sargent I, Redman C: An innate view of human pregnancy. Immunol Today. 1999, 20: 114-118. 10.1016/S0167-5699(98)01393-0.View ArticlePubMed
- Carding SR, Egan PJ: γδT cells: functional plasticity and heterogeneity. Nat Rev Immunol. 2002, 2: 336-345.View ArticlePubMed
- Bendelac A, Bonneville M, Kearney JF: Autoreactivity by design: innate B and T lymphocytes. Nature Rev Immunol. 2001, 117: 177-186. 10.1038/35105052.View Article
- Meeusen EN, Bischof RJ, Lee CS: Comparative T-cell responses during pregnancy in large animals and humans. Am J Reprod Immunol. 2001, 46: 169-179. 10.1111/j.8755-8920.2001.460208.x.View ArticlePubMed
- Mincheva-Nilsson L, Hammarström S, Hammarström M-L: Human decidual leukocytes from early pregnancy contain high numbers of γδ+ cells and show selective down-regulation of alloreactivity. J Immunol. 1992, 149: 2203-2211.PubMed
- Mincheva-Nilsson L, Baranov V, Yeung MM, Hammarström S, Hammarström M-L: Immunomorphologic studies of human decidua-associated lymphoid cells in normal early pregnancy. J Immunol. 1994, 152: 2020-2032.PubMed
- Sharma R, Bulmer D, Peel S: Effects of exogenous progesterone following ovariectomy on the metrial glands of pregnant mice. J Anat. 1986, 144: 189-199.PubMed CentralPubMed
- Mincheva-Nilsson L, Kling M, Hammarström S, Nagaeva O, Sundqvist K-G, Hammarström M-L, Baranov V: γδT cells of human early pregnancy decidua: evidence for local proliferation, phenotypic heterogeneity, and extrathymic differentiation. J Immunol. 1997, 159: 3266-3277.PubMed
- Parr EL, Young LH, Parr MB, Young JD: Granulated metrial gland cells of pregnant mouse uterus are natural killer cells that contain perforin and serine esterases. J Immunol. 1990, 145: 2365-2372.PubMed
- Saito S: Cytokine network at the feto-maternal interface. J Reprod Immunol. 2000, 47: 87-103. 10.1016/S0165-0378(00)00060-7.View ArticlePubMed
- Ashkar AA, DiSanto JP, Croy BA: Interferon gamma contributes to initiation of vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med. 2000, 192: 259-270. 10.1084/jem.192.2.259.PubMed CentralView ArticlePubMed
- Hayakawa S, Saito S, Nemoto N, Chishima F, Akiyama K, Shiraish H, Hayakawa J, Karasaki-Suzuki M, Fujii KT, Ichijo M, Sakurai I, Satoh K: Expression of recombinase-activating genes (RAG-1 and 2) in human decidual mononuclear cells. J Immunol. 1994, 153: 4934-4939.PubMed
- Kimura M, Hanawa H, Watanabe H, Ogawa M, Abo T: Synchronous expansion of intermediate TCR cells in the liver and uterus during pregnancy. Cell Immunol. 1995, 162: 16-25. 10.1006/cimm.1995.1046.View ArticlePubMed
- Chaplin DD: Overview of the immune response. J Allergy Clin Immunol. 2003, 111: S442-S459. 10.1067/mai.2003.125.View ArticlePubMed
- Chen ZW: Comparative biology of γδT cells. Science Progress. 2002, 85: 347-358.View ArticlePubMed
- Hayday A, Theodoridis E, Ramsburg E, Shires J: Intraepithelial lymphocytes: exploring the third way in immunology. Nat Immunol. 2001, 2: 997-1003. 10.1038/ni1101-997.View ArticlePubMed
- Rocha B, Vassalli P, Guy-Grand D: Thymic and extrathymic origins of gut intraepithelial populations in mice. J Exp Med. 1994, 180: 681-686.View ArticlePubMed
- Spada FM, Grant EP, Peters PJ, Sugita M, Melian A, Leslie DS, Lee HK, van Donselaar E, Hanson DA, Krensky AM: Self-recognition of CD1 by gamma/delta T cells: implication for innate immunity. J Exp Med. 2000, 191: 937-948. 10.1084/jem.191.6.937.PubMed CentralView ArticlePubMed
- Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T: Broad tumor-associated expression and recognition by tumor-derived γδT cells of MICA and MICB. Proc Natl Acad Sci USA. 1999, 96: 6879-6884. 10.1073/pnas.96.12.6879.PubMed CentralView ArticlePubMed
- Groh V, Steinle A, Bauer S, Spies T: Recognition of stress-induced MHC molecules by intestinal epithelial γδT cells. Science. 1998, 279: 1737-1740. 10.1126/science.279.5357.1737.View ArticlePubMed
- Mincheva-Nilsson L, Nagaeva O, Sundqvist KG, Hammarström ML, Hammarström S, Baranov V: γδT cells of early pregnancy decidua: evidence for cytotoxic potency. Int Immunol. 2000, 12: 585-596. 10.1093/intimm/12.5.585.View ArticlePubMed
- Hayday AC: γδT cells: A right time and a right place for a conserved third way of protection. Annu Rev Immunol. 2000, 18: 975-1026. 10.1146/annurev.immunol.18.1.975.View ArticlePubMed
- Kroka M, Tärnvik A, Sjöstedt A: The proportion of circulationg γδT cells increases after the first week of onset of tularemia and remains elevated for more than a year. Clin Exp Immunol. 2001, 120: 280-284. 10.1046/j.1365-2249.2000.01215.x.View Article
- Born W, Cady C, Jones-Carson J, Mukasa A, Lahn M, O'Brien R: Immunoregulatory functions of γδT cells. Adv Immunol. 1999, 71: 77-144.View ArticlePubMed
- Ferrarini M, Ferrero E, Dagna L, Poggi A, Zocchi MR: Human γδT cells: a nonredundant system in the immune-surveillance against cancer. Trends Immunol. 2002, 23: 14-18. 10.1016/S1471-4906(01)02110-X.View ArticlePubMed
- Billington WD: The nature and possible functions of MHC antigens on the surface of human trophoblast. In: Reproductive Immunology. Edited by: Gupta SK. 1999, Narosa Publishing house, New Delhi, India
- Szekeres-Bartho J, Barakonyi A, Miko E, Polgar B, Palkovics T: The role of γ/δT cells in the feto-maternal relationship. Semin Immunol. 2001, 13: 229-233. 10.1006/smim.2000.0318.View ArticlePubMed
- Szekeres-Bartho J, Barakonyi A, Polgar B, Par G, Faust Zs, Palkovics T, Szereday L: The role of γ/δT cells in progesteron-mediated immunomodulation during pregnancy. Am J Reprod Immunol. 1999, 42: 44-48.View ArticlePubMed
- Meeusen E, Fox A, Brandon M, Lee CS: Activation of uterine intraepithelial γδT cell receptor-positive lymphocytes during pregnancy. Eur J Immunol. 1993, 23: 1112-1117.View ArticlePubMed
- Morii T, Nishikawa K, Saito S, Enomoto M, Ito A, Kurai N, Shimoyama T, Ichijo M, Narita N: T-cell receptors are expressed but down-regulated on intradecidual T lymphocytes. Am J Reprod Immunol. 1993, 29: 1-4.View ArticlePubMed
- Christmas SE, Brew R, Deniz G, Taylor JJ: T cell receptor heterogeneity of γδT cell clones from human female reproductive tissues. Immunology. 1993, 78: 436-443.PubMed CentralPubMed
- Itohara S, Farr AG, Lafaille JJ, Bonneville M, Takagaki Y, Haas W, Tonegawa S: Homing of a gamma /delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia. Nature. 1990, 343: 754-757. 10.1038/343754a0.View ArticlePubMed
- Heyborne KD, Cranfill RL, Carding SR, Born WK, O'Brien RL: Characterization of γδT lymphocytes at the maternal-fetal interface. J Immunol. 1992, 149: 2872-2878.PubMed
- Bossi G, Griffiths GM: Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med. 1999, 5: 90-96. 10.1038/4779.View ArticlePubMed
- Spielman J, Lee RK, Podack ER: Perforin/Fas ligand double deficiency is associated with macrophage expansion and severe pancreatitis. J Immunol. 1998, 161: 7063-7070.PubMed
- Heyborne K, Fu Y-X, Nelson A, Farr A, O'Brien R, Born : Recognition of trophoblasts by γδT cells. J Immunol. 1994, 153: 2918-2926.PubMed
- Borowski C, Martin C, Gounari F, Haughn L, Aifantis I, Grassi F, von Boehmer H: On the brink of becoming a T cell. Curr Opin Immunol. 2002, 14: 200-206. 10.1016/S0952-7915(02)00322-9.View ArticlePubMed
- Clarke AG, Kendall MD: The thymus in pregnancy: the interplay of neural, endocrine and immune influences. Immunol Today. 1994, 15: 545-551. 10.1016/0167-5699(94)90212-7.View ArticlePubMed
- Boyd RL, Tucek CL, Godfrey DI, Izon DJ, Wilson TJ, Davidson NJ, Bean AG, Ladyman HM, Ritter MA, Hugo P: The thymic microenvironment. Immunol Today. 1993, 14: 445-459. 10.1016/0167-5699(93)90248-J.View ArticlePubMed
- Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B: T cell awareness of paternal alloantigens during pregnancy. Science. 1995, 270: 630-633.View ArticlePubMed
- Raghupathy R: Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol. 2001, 13: 219-227. 10.1006/smim.2001.0316.View ArticlePubMed
- Allen JE, Maizels RM: Th1-Th2: reliable paradigm or dangerous dogma?. Immunol Today. 1997, 8: 387-392.View Article
- Groux H: An overview of regulatory T cells. Microbes Infect. 2001, 3: 883-889. 10.1016/S1286-4579(01)01448-4.View ArticlePubMed
- Arck PC, Ferrick DA, Steele-Norwood D, Croitoru K, Clark DA: Regulation of abortion by γδT cells. Am J Reprod Immunol. 1997, 37: 87-93.View ArticlePubMed
- Nagaeva O, Jonsson L, Mincheva-Nilsson L: Dominant IL-10 and TGF-β mRNA expression in γδT cells of human early pregnancy decidua suggests immunoregulatory potential. Am J Reprod Immunol. 2002, 48: 9-17. 10.1034/j.1600-0897.2002.01131.x.View ArticlePubMed
- Salamonsen LA, Dimitriadis E, Robb L: Cytokines in implantation. Semin Reprod Med. 2000, 18: 299-310. 10.1055/s-2000-12567.View ArticlePubMed
- Roncarolo MG, Levings MK: The role of different subsets of regulatory cells in controlling autoimmunity. Curr Opin Immunol. 2000, 12: 676-683. 10.1016/S0952-7915(00)00162-X.View ArticlePubMed
- Ymagiwa S, Gray JD, Hashimoto A, Horwitz DA: A role for TGF-β in the generation and expansion of CD4+CD25+ regulatory cells from human peripheral blood. J Immunol. 2001, 166: 7282-7289.View Article
- Groux H, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997, 389: 737-742. 10.1038/39614.View ArticlePubMed
- Weiner HL: The mucosal milieu creates tolerogenic dendritic cells and Tr1 and Th3 regulatory cells. Nat Immunol. 2001, 2: 671-672. 10.1038/90604.View ArticlePubMed
- Hänninen A, Harrison LC: γδT cells as mediators of mucosal tolerance: the autoimmune diabetes model. Immunol Rev. 2000, 173: 109-119. 10.1034/j.1600-065X.2000.917303.x.View ArticlePubMed
- Gorczynski RM, Chen Z, Zeng H, Ming Fu X: Specificity for in vivo graft prolongation in γδT cell receptor+ hybridomas derived from mice given portal vein donor-specific preimmunization and skin allografts. J Immunol. 1997, 159: 3698-3706.PubMed
- Mukasa A, Yoshida H, Kobayashi N, Matsuzaki G, Nomoto K: γδT cells in infection-induced and autoimmune-induced testicular inflammation. Immunology. 1998, 95: 395-401. 10.1046/j.1365-2567.1998.00585.x.PubMed CentralView ArticlePubMed
- Leslie DS, Vincent MS, Spada FM, Das H, Sugita M, Morita CT, Brenner BM: CD1-mediated γδT cell maturation of dendritic cells. J Exp Med. 2002, 196: 1575-1584. 10.1084/jem.20021515.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.